Industry Overview
Introduction to the pharmaceutical industry worldwide
3 basic categories:
- Research based pharmaceutical companies
- Generic drug manufacturers
- OTC ( Over the counter) pharmaceutical companies. Some companies are active in more than one of the categories mentioned.
Characteristics of research based pharmaceutical companies
- Innovative. High expenditures into Research and Development
- Often global players
- Sophisticated marketing and educational activities
- Provide value for money
Drop in death rates for diseases treated with pharmaceuticals 1965 - 1996
| Disease |
Treatment |
% drop in death rate |
| Rheumatic fever and rheumatic heart disease |
Antibiotics |
83% |
| Atherosclerosis |
ACE inhibitors, Beta Blockers, nitrates |
74% |
| Ulcer of stomach and duodenum |
H2 Blockers, proton pump inhibitors |
72% |
| Ischemic heart disease |
ACE inhibitors, Beta Blockers, nitrates |
62% |
| Emphysema |
Anti-inflammatories, bronchodilators |
57% |
Source: PhRMA
R&D expenditures in % of sales
| US based research based pharmaceutical companies |
20.8% |
| Global pharmaceutical sector |
17.3% |
| Computer software and services |
9.3% |
| Office equipment and services |
9.3% |
| Electrical and electronic devices |
6.4% |
| Telecommunications |
5.7% |
| All industries excluding pharma |
4.1% |
Source: PhRMA
Company financed R&D by product class in 2000
| Central nervous system |
22.8 billion MR |
| Neoplasms, endocrine and metabolicdiseases |
19.0 billion MR |
| Cardiovascular system |
15.6 billion MR |
| Infective and parasitic diseases |
13.7 billion MR |
| Biologicals |
9.1 billion MR |
| Others |
93.5 billion MR |
| Total |
164.5 billion MR |
Source: PhRMA & IFPMA
Global Pharmaceutical Sales in 2000 by Region in billion MR
580+14% North America
286+8% Europe
196+3% Japan
72+9% Latin America
71+10% Asia,Africa,Australia
Pharmaceutical Market in Malaysia
- Over 100 pharmaceutical companies
- Most of the world largest pharmaceutical companies are represented
- Total market estimated at MR 1.4 billion
- Growth in 2000 of over 15%
Distribution channels of pharmaceuticals in Malaysia
30% Pharmacies
26% Doctors
19% Government hospitals
14% Private hospitals
11% others
Print
Friendly
|